Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Enterprise 2 Vascular Reconstruction Device

NCT: NCT05254067 · COMPLETED

NCT IDNCT05254067
StatusCOMPLETED
Start Date2017-02-28
Completion2026-01-05
SponsorMethodist Health System (OTHER)
First posted
Last updated

Brief Summary

The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck configuration.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑